MHRA reminds prescribers about nitrofurantoin risks

Healthcare professionals have been reminded of the risks of using nitrofurantoin in patients with renal impairment, in a recent edition of the MHRA's Drug Safety Update.

by
Urinary tract infections, including those caused by E. coli (pictured), can be treated with nitrofurantoin provided the patient has no significant degree of renal impairment | SCIENCE PHOTO LIBRARY
Urinary tract infections, including those caused by E. coli (pictured), can be treated with nitrofurantoin provided the patient has no significant degree of renal impairment | SCIENCE PHOTO LIBRARY

To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content.

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package